MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: Association with muscle involvement

被引:60
作者
O'Connor, Kevin A.
Abbott, Kathy A.
Sabin, Brad
Kuroda, Maxine
Pachman, Lauren M.
机构
[1] Childrens Mem Res Ctr, Mol & Cellular Pathobiol Program, Chicago, IL 60614 USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Childrens Mem Med Ctr, Div Immunol Rheumatol, Chicago, IL 60614 USA
关键词
juvenile dermatomyositis; interferon; MxA; PBMC; muscle;
D O I
10.1016/j.clim.2006.05.011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Juvenile dermatomyositis (JDM), a systemic vasculopathy, is characterized by inflammation of skin and muscle. Muscle biopsies from untreated JDM patients show upregulation of type I interferon (IFN)-inducible genes, including myxovirus resistance protein A (MxA). The present study examines whether MxA mRNA expression in peripheral blood mononuclear cells (PBMC) from JDM patients: (1) is elevated compared to healthy controls, (2) reflects disease activity, and (3) changes with the onset of clinically effective treatment. MxA mRNA expression in JDM PBMC obtained at the initial clinic visit was elevated compared to controls and was positively correlated with Disease Activity Score (DAS) for muscle, but not with DAS for skin, suggesting that damage to skin and muscle in JDM may each have a discrete pathophysiology. During the course of clinically effective treatment, decrease in muscle symptoms was associated with a decrease in PBMC MxA mRNA expression. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:319 / 325
页数:7
相关论文
共 36 条
[1]   Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-α therapy [J].
Antonelli, G ;
Simeoni, E ;
Turriziani, O ;
Tesoro, R ;
Redaelli, A ;
Roffi, L ;
Antonelli, L ;
Pistello, M ;
Dianzani, F .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (03) :243-251
[2]   Activation of the type I interferon system in primary Sjogren's syndrome -: A possible etiopathogenic mechanism [J].
Båve, U ;
Nordmark, G ;
Lövgren, T ;
Rönnelid, J ;
Cajander, S ;
Eloranta, ML ;
Alm, GV ;
Rönnblom, L .
ARTHRITIS AND RHEUMATISM, 2005, 52 (04) :1185-1195
[3]   Evaluation of bioavailability of three types of IFNβ in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification [J].
Bertolotto, A ;
Gilli, F ;
Sala, A ;
Audano, L ;
Castello, A ;
Magliola, U ;
Melis, F ;
Giordana, MT .
JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 256 (1-2) :141-152
[4]   Role of early cytokines, including alpha and beta interferons (IFN-α/β), in innate and adaptive immune responses to viral infections [J].
Biron, CA .
SEMINARS IN IMMUNOLOGY, 1998, 10 (05) :383-390
[5]   Disease activity score for children with juvenile dermatomyositis: Reliability and validity evidence [J].
Bode, RK ;
Klein-Gitelman, MS ;
Miller, ML ;
Lechman, TS ;
Pachman, LM .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2003, 49 (01) :7-15
[6]   POLYMYOSITIS AND DERMATOMYOSITIS .2. [J].
BOHAN, A ;
PETER, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (08) :403-407
[7]   POLYMYOSITIS AND DERMATOMYOSITIS .1. [J].
BOHAN, A ;
PETER, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (07) :344-347
[8]   Microarray analysis of interferon-regulated genes in SLE [J].
Crow, MK ;
Kirou, KA ;
Wohlgemuth, J .
AUTOIMMUNITY, 2003, 36 (08) :481-490
[9]   Dermatomyositis after interferon alpha treatment [J].
Dietrich, LL ;
Bridges, AJ ;
Albertini, MR .
MEDICAL ONCOLOGY, 2000, 17 (01) :64-69
[10]   Plasmacytoid dendritic cells (natural interferon-α/β-producing cells) accumulate in cutaneous lupus erythematosus lesions [J].
Farkas, L ;
Beiske, K ;
Lund-Johansen, F ;
Brandtzaeg, P ;
Jahnsen, FL .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) :237-243